| 1 |
PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia.
61
|
Richter-Pechanska P...Kulozik AE
|
30389682 |
2018 |
| 2 |
Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.
61
|
Ding J...Kelley MR
|
28446640 |
2017 |
| 3 |
Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison.
61
|
Orentas RJ...Khan J
|
24959420 |
2014 |
| 4 |
Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia.
61
|
Brandao LN...Graham DK
|
23353780 |
2013 |
| 5 |
The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.
61
|
Zuurbier L...Meijerink JP
|
22491738 |
2012 |
| 6 |
Novel methodology for the follow-up of acute lymphoblastic leukemia using FTIR microspectroscopy.
61
|
Ramesh J...Mordechai S
|
12088885 |
2002 |
| 7 |
Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials.
61
|
Bennett CL...Laver JH
|
10657867 |
2000 |
